Navigation Links
New analysis finds daycare attendance early in life cuts childhood leukemia risk by 30 percent
Date:4/28/2008

mutation in the womb, followed by a second trigger during childhood that results in 1% of those children developing the disease. Infection or the timing of infection - is one of the suspected triggers.

Bufflers analysis included 14 published studies comprising a total of 6,108 children with leukaemia and 13,704 without the disease. Parents were asked about day care and playgroup attendance, as well as other forms of social interaction with other children. The studies varied in the timing, duration and extent of social contact investigated and in the age groups and types of leukaemia studied. Twelve of the studies found some indication of a protective effect of social interaction with other children, while two found no effect. No study found that social contact increased the risk of childhood leukaemia.

Our analysis concluded that children who attended day care or play groups had about a 30% lower risk of developing leukaemia than those who did not. Combined results for studies of day care attendance specifically before the age of 1 or 2 showed a similarly reduced risk, Buffler said.

The protective effect became even stronger when the researchers omitted from the analysis 5 studies in which the selection of healthy children for the comparison group relied on methods not considered optimal. In that analysis, children exposed to social contact were almost 40% less likely to go on to develop leukaemia than their counterparts.

In a separate report released at the conference on Tuesday by CHILDREN with LEUKAEMIA, scientists reviewed the evidence from studies that have investigated a link between infection and childhood leukaemia. They examined not only the idea that early life infections protect against the disease but also whether vaccination plays a role. In addition, they examined two other related areas of research: the role of infection during pregnancy and whether infection might be a factor influencing childhood leukaemia risk
'/>"/>

Contact: Emma Ross
rosswrite@mac.com
44-796-823-8209
Children With Leukaemia
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study, meta-analysis examine factors associated with death from heatstroke
2. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
3. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
4. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
5. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
6. Physical Therapist Provides Injury Analysis for Fantasy Football
7. Sanofi-Aventis renews licenses for Genomatix chip analysis pipeline
8. Meta-Analysis of Blood Phe Levels and Clinical Outcomes in PKU Published
9. OCS and Press Ganey Partner to Create Joint Analysis of Outcomes and Satisfaction
10. New Analysis Underscores Legality of Physician Ranking and Public Reporting Systems When Used by Health Insurers to Improve Health Care Quality
11. Barta joins Conseco as Senior Vice President, Financial Planning & Analysis; Barra named Senior Vice President, Internal Audit; Clarke to head Investor Relations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...cer Institute,s cancer registry has found that as ... or incomplete radiation treatment following breas...e can lead to worse outcomes. , Dr. Heather Taff...agues found that among a nationally representative...ients aged 65 and older, almost 1,300 women experi...
(Date:12/1/2008)...re/ -- Due to the urgent need to disseminate autho...arch and clinical care, publisher Mary Ann Liebe... all archival online issues of the company,s AIDS ...orld AIDS Day. Free online access is available for...om/apc ) and AIDS Research and Human Retroviruse...
(Date:12/1/2008)...swire/ -- Americans United for Life (AUL) today ... resolution opposing the federal "Freedom of Choic...opt the resolution immediately when they convene t..., AUL President & CEO said, "The so-called ,Fr... protects and promotes the abortion industry, sacr...
(Date:12/1/2008)...stCall/ -- Senetek PLC,(OTC Bulletin Board: SNKTY...ment of technologies that target the science of he...AG, specialists in the fields of strategic,develo...offices in Zurich,Bern and Geneva has published ...earch Report, available in the "Investors" section...
Breaking Medicine News(10 mins):Health News:Delays in radiation therapy lead to increased breast cancer recurrence 2Health News:Mary Ann Liebert, Inc. Provides Free Online Journal Access in Recognition of World AIDS Day 2Health News:Americans United for Life Urges State Legislatures to Oppose Federal Power Grab: Provides Model Resolution Denouncing Freedom of Choice Act (FOCA) 2
...nam's first human death from bird flu in more than...farmers in fighting the virus that remains endemic...ld man from a province neighbouring the capital Ha...e communist government said, and four more people ...
...w study has revealed that children born after embr...GD) do not show any more major malformations than ...gies (ART) without PGD. PGD is a new option for c...ic diseases. Instead of carrying out a prenatal di...
...w study has found that waiting just two minutes to...es a 'significant' health boost as it reduces the ... by boffins at McMaster University in Hamilton, Ca...ewborns. Lead author Eileen Hutton, assistant dean...
... sleuths believe they may have identified potentia..., a disfiguring and sometimes fatal disease that a...Their comparison of three species of protozoa that...r drug engineers, whose budgets for tackling this ...
Other Medicine News:Health News:Vietnam Bird Flu Death a Call for Action, Say Experts 2Health News:Vietnam Bird Flu Death a Call for Action, Say Experts 3Health News:Children Born After PGD as Healthy as Kids Born After ART 2Health News:2 Minute Delay in Cutting Cord can Give Babies a 'significant' Health Boost 2Health News:Gene Study Throws Up New Targets for Leishmaniasis 2
(Date:12/1/2008)...led for Tuesday, December 9 at 11:00 am ET to Disc...UTH SAN FRANCISCO, Calif., Dec. 1 /PRNewswire-Fi... SNSS ), a biopharmaceutical company focused on ...ogy therapeutics, today announced new data from it...AML) will be presented during the 50th American So...
(Date:11/28/2008)...vember 28 German biotech company,...alized HIV monitoring and,AIDS patient follow-up ... In,the year 2008, 2.5 million patient tests have...hly affordable "CyFlow" system, supporting already... Due to introduction of the,Partec innovation, th...
(Date:11/26/2008)...jects , , FRANKLIN, Mass., Nov. 26 /PRNewsw...oard: PLCSF) announced today that it has received ...ration (FDA) for its U.S. pivotal trial to study t...m(TM) and associated therapy in the prevention of...e FDA also approved PLC,s request to expand their ...
(Date:11/25/2008)...f., Nov. 25 Poniard,Pha...eutical company focused on,innovative oncology th...,strategic alternatives for its preclinical resea...us its resources on the clinical development of pi...ort the initial commercialization of,picoplatin i...
Breaking Medicine Technology:Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Arpida Presents Preclinical Data on AR 2474 at ICAAC 723 1Arpida Presents Preclinical Data on AR 2474 at ICAAC 723 2Arpida Presents Preclinical Data on AR 2474 at ICAAC 723 3Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 345 1Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 345 2Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 345 3Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 345 4Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 345 5One Year Study of Exenatide Treatment Showed Improved Beta Cell Function 342 1One Year Study of Exenatide Treatment Showed Improved Beta Cell Function 342 2One Year Study of Exenatide Treatment Showed Improved Beta Cell Function 342 3One Year Study of Exenatide Treatment Showed Improved Beta Cell Function 342 4One Year Study of Exenatide Treatment Showed Improved Beta Cell Function 342 5One Year Study of Exenatide Treatment Showed Improved Beta Cell Function 342 6One Year Study of Exenatide Treatment Showed Improved Beta Cell Function 342 7Multiple corticosteroid injections in pregnant women may increase cerebral palsy 1712 1Multiple corticosteroid injections in pregnant women may increase cerebral palsy 1712 2
...CH TRIANGLE PARK, N.C. & SHERBROOKE, Quebec--(...leading biopharmaceutical,company developing small...nal and metabolic diseases, today announced positi... in accelerating,gastric emptying in diabetic pati...se IIa study were presented at the American,Diabet...
...reece--(BUSINESS WIRE)--Jun 26, 2007 - Acceleron P...g therapeutics for the,treatment of musculoskeleta...nounced results demonstrating that ACE-011, a,nove...ss, preserved,bone mass and architecture in a muri...a malignancy of plasma cells in the bone marrow,th...
Other Medicine Technology:Tranzyme Pharma Presents Initial Phase IIa Data for its Novel,Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis 2Tranzyme Pharma Presents Initial Phase IIa Data for its Novel,Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis 3ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical,Model 2ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical,Model 3
...-I or somatomedin C) is a 7.6 kDa peptide produced...en of cellular proliferation, exerting its actions... the circulation, IGF-I is bound to IGF-binding pr...ons of IGF-I by modulating the interaction of IGF-...
...-I or somatomedin C) is a 7.6 kDa peptide produced...en of cellular proliferation, exerting its actions... the circulation, IGF-I is bound to IGF-binding pr...ons of IGF-I by modulating the interaction of IGF-...
...-I or somatomedin C) is a 7.6 kDa peptide produced...en of cellular proliferation, exerting its actions... the circulation, IGF-I is bound to IGF-binding pr...ons of IGF-I by modulating the interaction of IGF-...
... potent naturally occurring androgen produced from...a-reductase [1]. The concentrations of 5a-reducta...uding genital skin and hair follicles, and are loc...th the nuclear membrane. DHT exerts its biologica...
Medicine Products: